Mycobacterium tuberculosis is the etiologic agent of tuberculosis which remains the leading cause of mortality due to an identifiable infectious agent worldwide. Most individuals successfully contain a primary infection and develop a vigorous delayed-type hypersensitivity (DTH) response to mycobacterial antigens. T. cells are thought to play a critical role in the immune response which follows infection with M. tuberculosis. They mediate and regulate the acquired immune response which controls primary infection and provides protection against exogenous reinfection. Failure of the T cell response contributes to progressive primary infection and to reactivation of endogenous foci of mycobacteria. Based on studies in humans and animal models, the CD4+ T cell traditionally has been considered the main T cell subset responsible for regulating the protective immune response to M. tuberculosis. Studies by us (supported by AI27243) and others, however, have demonstrated that the CD4+ T cell can serve directly as effector cells through cytotoxicity for mononuclear phagocytes heavily infected with mycobacteria. Furthermore, in addition to the CD4+ T cell, gammadelta T cell receptor bearing T cells (gammadelta T cell, CD4-,CD8-) have been found to be a major reactive T cell population to M. tuberculosis. In studies supported by AI27243, we have demonstrated that gammadelta T cells are particularly reactive to live M. tuberculosis, which suggests that gammadelta T cells may play an important role in the innate or primary immune response to live intracellular organisms. These findings support a model of complementary roles for CD4+ and gammadelta T cells in the immune response to M. tuberculosis as follows. There are three specific aims to test this model: 1. To determine the mechanisms by which ingestion of live M. tuberculosis results in the induction of human gamma/delta T cells, by characterizing pathways of antigen-processing and requirements for MHC-like restriction elements, and by characterizing the role of mycobacterial viability and virulence. 2. To compare the antigenic repertoire and profiles of cytokines, likely to be involved in mononuclear phagocyte activation (IL-2,GM-CSF-TNF-alpha), of human CD4+ and gammadelta T cells reactive to M. tuberculosis. 3. To compare the functions of CD4+ and gammadelta T cells relative to mononuclear phagocytes infected with M. tuberculosis, in terms of cytotoxicity, phagocytosis and mycobacterial killing and to determine the role of the load of mycobacteria in the expression of these functions. The proposed studies will provide new insights into the relative and complementary roles of the two major reactive T cell populations, CD4+ and gammadelta T cells, in the human immune response to M. tuberculosis. An understanding of the T cell response to this pathogen will contribute to the design of improved methods of prevention and diagnosis of tuberculosis. This is a health related project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027243-06
Application #
2063769
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1989-02-01
Project End
1997-01-31
Budget Start
1994-02-01
Budget End
1995-01-31
Support Year
6
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Shukla, Supriya; Richardson, Edward T; Drage, Michael G et al. (2018) Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes. Infect Immun 86:
Athman, Jaffre J; Sande, Obondo J; Groft, Sarah G et al. (2017) Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation. J Immunol 198:2028-2037
Karim, Ahmad Faisal; Reba, Scott M; Li, Qing et al. (2017) Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function. Eur J Immunol 47:1513-1524
Karim, Ahmad F; Sande, Obondo J; Tomechko, Sara E et al. (2017) Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4+ T Cells by Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan. Proteomics 17:
Li, Qing; Karim, Ahmad F; Ding, Xuedong et al. (2016) Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis. Sci Rep 6:27566
Sande, Obondo J; Karim, Ahmad F; Li, Qing et al. (2016) Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL. J Immunol 196:691-702
Athman, Jaffre J; Wang, Ying; McDonald, David J et al. (2015) Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages. J Immunol 195:1044-53
Richardson, Edward T; Shukla, Supriya; Sweet, David R et al. (2015) Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells. Infect Immun 83:2242-54
Richardson, Edward T; Shukla, Supriya; Nagy, Nancy et al. (2015) ERK Signaling Is Essential for Macrophage Development. PLoS One 10:e0140064
Shukla, Supriya; Richardson, Edward T; Athman, Jaffre J et al. (2014) Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog 10:e1004471

Showing the most recent 10 out of 79 publications